Henry Schein, Inc.
NASDAQ:HSICMedical - Distribution
-$1.24 today
- Market cap
- $9.47B
- Beta
- 0.82
- P/E (TTM)
- 23.3
- EPS (TTM)
- $3.44
Volume 2.08M
Average 1.39M
HSIC Deferred Revenue
Payments received for goods or services the company will deliver within the next year.
Henry Schein, Inc.NASDAQ: HSIC
Deferred Revenue · Q2 FY2026 · quarter ended Jun 2026
Deferred revenue remains negative
Q2 FY2026 deferred revenue was $0, compared with $0 a year earlier.
Context
- Deferred revenue amounted to 0.0% of total assets at the end of Q2 FY2026, unchanged from a year earlier.
- Deferred revenue increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-27 | 0 | — |
| FY2024 | 2024-12-28 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Deferred Revenue vs competitors
How HSIC compares with its peers on the latest reported figures
- HSIC's Jun 2026 deferred revenue of $0 is the highest of the 7 companies compared; the peer median is $0.
- Deferred revenue amounts to 0.0% of total assets for HSIC, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Jun 2026 | $0 | — | — | 0.0% | |
| Sep 2026 | $0 | — | — | 0.0% | |
| Oct 2026 | $0 | -100.0% | +32.8% | 0.0% | |
| Mar 2026 | $0 | — | -4.1% | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding HSIC) | $0 | -100.0% | +14.3% | 0.0% | |
Competitors are the stored peer set for HSIC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 118M | 117M | 171M | 122M | 156M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 1.45B | 1.44B | 1.86B | 1.48B | 1.65B |
| Inventory | 1.86B | 1.96B | 1.82B | 1.81B | 2B |
| Other Current Assets | (103K) | 466M | 639M | 569M | 655M |
| Total Current Assets | 3.84B | 3.99B | 4.49B | 3.98B | 4.46B |
| Property, Plant & Equipment (Net) | 691M | 667M | 823M | 824M | 922M |
| Goodwill | 2.85B | 2.89B | 3.88B | 3.89B | 4.21B |
| Intangible Assets | 668M | 587M | 916M | 1.02B | 1.02B |
| Long-term Investments | 168M | 161M | 180M | 170M | 174M |
| Tax Assets | 35M | 88M | 38M | 47M | 92M |
| Other Non-current Assets | 221M | 223M | 253M | 284M | 332M |
| Total Non-current Assets | 4.64B | 4.62B | 6.09B | 6.24B | 6.75B |
| Total Assets | 8.48B | 8.61B | 10.57B | 10.22B | 11.22B |
| Account Payables | 1.05B | 1B | 1.02B | 962M | 1.15B |
| Short-term Debt | 62M | 109M | 414M | 706M | 875M |
| Tax Payables | 136.92M | 132M | 137M | 139M | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 0 | 0 | 0 | 680M |
| Total Current Liabilities | 2.31B | 2.22B | 2.68B | 2.8B | 3.23B |
| Long-term Debt | 811M | 1.04B | 1.94B | 1.83B | 2.56B |
| Deferred Tax Liabilities | 42M | 36M | 54M | 102M | 146M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 8M | 0 |
| Other Non-current Liabilities | 377M | 361M | 436M | 379M | 235M |
| Total Non-current Liabilities | 1.5B | 1.71B | 2.74B | 2.58B | 3.19B |
| Total Liabilities | 3.81B | 3.94B | 5.42B | 5.38B | 6.42B |
| Common Stock | 1M | 1M | 1M | 1M | 1M |
| Retained Earnings | 3.6B | 3.68B | 3.86B | 3.77B | 3.29B |
| Accumulated OCI | (171M) | (233M) | (206M) | (379M) | (226M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 1.25B | 1.23B | 1.5B | 1.44B | 1.55B |
| Total Equity | 4.68B | 4.67B | 5.15B | 4.84B | 4.79B |
| Total Debt | 1.22B | 1.5B | 2.74B | 2.87B | 3.69B |
| Net Debt | 1.1B | 1.38B | 2.57B | 2.75B | 3.53B |
Henry Schein, Inc.
NASDAQ:HSIC
Intrinsic Alpha fair value
Locked
Current Price
$85.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.